secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001493152-23-037575
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed subsidiary Lucid Diagnostics raises $5M via Series A-1 Convertible Preferred Stock
--------------------------------------------------------------------------------

- Lucid Diagnostics, majority-owned PAVmed sub, sold 5,000 shares of newly designated Series A-1 Convertible Preferred at $1,000/share.
- Gross proceeds of $5.0 million from accredited investors; private placement closed October 18, 2023.
- Certificate of Designation and Registration Rights Agreement filed by Lucid on Form 8-K; terms incorporated by reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223037575/0001493152-23-037575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223037575/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer